Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             25 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer Sato, Yasushi
2015
75 3 p. 587-594
artikel
2 Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma D’ Angelo, Sandra P.
2015
75 3 p. 629-638
artikel
3 A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer Soejima, Kenzo
2015
75 3 p. 513-519
artikel
4 A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer Choi, Dae Ro
2015
75 3 p. 639-643
artikel
5 A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine Newman, Edward M.
2015
75 3 p. 537-546
artikel
6 A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer Yamazaki, Kentaro
2015
75 3 p. 569-577
artikel
7 Autophagy modulation: a target for cancer treatment development Duffy, Alison
2014
75 3 p. 439-447
artikel
8 Dosing algorithm revisit for busulfan following IV infusion Wang, Yanlin
2015
75 3 p. 505-512
artikel
9 Effect of axitinib on the QT interval in healthy volunteers Ruiz-Garcia, Ana
2015
75 3 p. 619-628
artikel
10 Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease Kenmotsu, Hirotsugu
2015
75 3 p. 521-526
artikel
11 Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial Chen, Zhiyu
2015
75 3 p. 547-557
artikel
12 Erratum to: Does saturable formation of gemcitabine triphosphate occur in patients? Tham, Lai-San
2015
75 3 p. 657
artikel
13 Intermittent dosing of aromatase inhibitors (AI) to improve tolerance in postmenopausal women: a rationale for future clinical studies Salmon, R.
2015
75 3 p. 653-655
artikel
14 Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer Liu, Ying
2015
75 3 p. 645-651
artikel
15 Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus Géresi, Krisztina
2015
75 3 p. 609-618
artikel
16 Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma Joshi, Shweta
2015
75 3 p. 595-608
artikel
17 Pharmacokinetics of neamine in rats and anti-cervical cancer activity in vitro and in vivo Liu, Yaping
2014
75 3 p. 465-474
artikel
18 Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer Miyazaki, Tatsuya
2014
75 3 p. 449-455
artikel
19 Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer Han, Ji-Youn
2014
75 3 p. 475-483
artikel
20 Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients Chang, T. C.
2015
75 3 p. 579-586
artikel
21 Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing Nikanjam, Mina
2015
75 3 p. 495-503
artikel
22 Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice Justino, Priscilla F. C.
2015
75 3 p. 559-567
artikel
23 Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival Kasuga, Akiyoshi
2014
75 3 p. 457-464
artikel
24 Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study Merchan, Jaime R.
2015
75 3 p. 485-493
artikel
25 The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer Kaku, Yoshiko
2015
75 3 p. 527-535
artikel
                             25 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland